Tilray Brands (TSE:TLRY) Trading Down 12.6% - Time to Sell?

Key Points

• Tilray Brands' stock decreased by 12.6% during trading, with prices dropping to as low as C$2.54, while the trading volume surged to 4.6 million shares, reflecting a 68% increase from the average.
• The company has a market cap of C$2.76 billion and a notably high debt-to-equity ratio of 10.76, indicating significant leverage.
• Despite current challenges, Tilray's Q3 earnings report suggested growth opportunities in both the Canadian and international medical cannabis markets.

Tilray Brands, Inc. (TSE:TLRY - )'s stock price traded down 12.6% during mid-day trading on Friday . The company traded as low as C$2.54 and last traded at C$2.57. 4,605,604 shares traded hands during trading, an increase of 68% from the average session volume of 2,748,626 shares. The stock had previously closed at C$2.94.

Tilray Brands Stock Down 15.3%

The business has a 50 day moving average of C$1.69 and a 200-day moving average of C$1.04. The stock has a market cap of C$2.76 billion, a PE ratio of -1.01 and a beta of 3.88. The company has a current ratio of 2.54, a quick ratio of 2.16 and a debt-to-equity ratio of 10.76.

Tilray Brands Company Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.